← Retour aux résultats de rechercheProfil de l'investisseur:
Profil de l'investisseur:
OrbiMed
Adresse:New York, New York, United States
Pays:
OrbiMed is a healthcare-dedicated investment firm focusing on biopharmaceuticals to medical devices and diagnostics.
Total des transactions: 223
En tant qu'investisseur principal: 111
Également comme investisseur secondaire : 10
En tant que second investisseur: 102
September 24, 2025$95mSecond investisseur
September 24, 2025
$95m
Sparrow Pharmaceuticals Raises $95M in Series B Financing
Second investisseur
Sparrow Pharmaceuticals Raises $95M in Series B Financing
September 22, 2025$60mInvestisseur principal
September 22, 2025
$60m
Avenzo Therapeutics Raised $60M in Series B Funding
Investisseur principal
Avenzo Therapeutics Raised $60M in Series B Funding
September 8, 2025$60mSecond investisseur
September 8, 2025
$60m
Epigenic Therapeutics Closes $60M Series B Financing
Second investisseur
Epigenic Therapeutics Closes $60M Series B Financing
September 4, 2025$32mInvestisseur principal
September 4, 2025
$32m
Congruence Therapeutics Raises $32M in Funding
Investisseur principal
Congruence Therapeutics Raises $32M in Funding
September 2, 2025
September 2, 2025